Latest news
25 items- SECSEC Form S-1/A filed by Celsion Corporation (Amendment)S-1/A - Imunon, Inc. (0000749647) (Filer)
- SECCelsion Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Imunon, Inc. (0000749647) (Filer)
- SECSEC Form S-1 filed by Celsion CorporationS-1 - Imunon, Inc. (0000749647) (Filer)
- INSIDERHazard Sebastien was granted 20,000 shares (SEC Form 4)4 - Imunon, Inc. (0000749647) (Issuer)
- INSIDERNew insider Hazard Sebastien claimed no ownership of stock in the company (SEC Form 3)3 - Imunon, Inc. (0000749647) (Issuer)
- SECSEC Form 8-K filed by Celsion Corporation8-K - Imunon, Inc. (0000749647) (Filer)
- SECSEC Form S-8 filed by Celsion CorporationS-8 - Imunon, Inc. (0000749647) (Filer)
- SECSEC Form 10-Q filed by Celsion Corporation10-Q - Imunon, Inc. (0000749647) (Filer)
- SECCelsion Corporation filed SEC Form 8-K: Financial Statements and Exhibits8-K - Imunon, Inc. (0000749647) (Filer)
- SECSEC Form 8-K filed by Celsion Corporation8-K - Imunon, Inc. (0000749647) (Filer)
- SECCelsion Corporation filed SEC Form 8-K: Leadership Update8-K - Imunon, Inc. (0000749647) (Filer)
- SECSEC Form 10-Q filed by Celsion Corporation10-Q - Imunon, Inc. (0000749647) (Filer)
- SECCelsion Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Imunon, Inc. (0000749647) (Filer)
- SECSEC Form DEF 14A filed by Celsion CorporationDEF 14A - Imunon, Inc. (0000749647) (Filer)
- SECSEC Form DEFA14A filed by Celsion CorporationDEFA14A - Imunon, Inc. (0000749647) (Filer)
- SECSEC Form 10-K filed by Celsion Corporation10-K - Imunon, Inc. (0000749647) (Filer)
- SECCelsion Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Imunon, Inc. (0000749647) (Filer)
- SECCelsion Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Imunon, Inc. (0000749647) (Filer)
- INSIDERSEC Form 4 filed by Braun Donald P4 - Imunon, Inc. (0000749647) (Issuer)
- INSIDERSEC Form 4 filed by Chow Pok Yu Augustine4 - Imunon, Inc. (0000749647) (Issuer)
- INSIDERSEC Form 4 filed by Fritz Frederick J.4 - Imunon, Inc. (0000749647) (Issuer)
- INSIDERSEC Form 4 filed by Pellizzari Christine A4 - Imunon, Inc. (0000749647) (Issuer)
- INSIDERSEC Form 4 filed by Dentzer James E4 - Imunon, Inc. (0000749647) (Issuer)
- INSIDERSEC Form 4 filed by Lindborg Stacy4 - Imunon, Inc. (0000749647) (Issuer)
- INSIDERSEC Form 4 filed by Tardugno Michael H4 - Imunon, Inc. (0000749647) (Issuer)
CLSN FAQ
5 questionsWhat does Celsion Corporation do?
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and vaccines. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for the treatment of primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product, which is in Phase II clinical trials for the localized treatment of ovarian cancers. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.Where does CLSN stock trade?
Celsion Corporation (CLSN) is listed on NASDAQ.What sector and industry is CLSN in?
Celsion Corporation operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What companies are similar to CLSN?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare CLSN side-by-side with any of them on Quantisnow.How can I track CLSN on Quantisnow?
Quantisnow aggregates Celsion Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CLSN to receive live email and push alerts on every new disclosure.